NCT02149966View on ClinicalTrials.gov

A Phase I Study of AG-348 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

AG-348

A range of doses of AG-348 will be tested based on the assessment of safety and tolerability. AG-348 will be administered by mouth (orally) each day for a period of 14 days.

DRUG

Placebo

Placebo will be administered by mouth (orally) each day for a period of 14 days.

Trial Locations (1)

21225

Baltimore

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY